Helix Biopharma Corp (HBPCF)

Helix Biopharma Corp (HBPCF)

Helix Biopharma Corp (HBPCF)

Helix BioPharma Corp. develops innovative products for the prevention and treatment of cancer based on its proprietary technologies.
Founded
1995
Raised
$6.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$1,800,000
Post-IPO equity - 2016
$4,700,000
Post-IPO equity - 2016
Team Size
2
Employees
Location
Headquarters
$1,800,000 Post-IPO equity
Marketwire

Helix BioPharma Corp. Closes CAD1.8 Million Private Placement

Science
$4,700,000 Post-IPO equity
Marketwire

Helix BioPharma Corp. Closes CAD4.7 Million Private Placement Financing

Science